In this CE Concepts Journal Club, expert faculty will assess emerging data on bispecific antibodies and co-stimulatory immune modulators presented at the ESMO-IO Congress and interpret safety and efficacy profiles of novel immuno-oncology agents to inform therapeutic decision-making in mNSCLC. This enduring, interactive activity will provide timely insights to support informed care planning and improved outcomes for patients with advanced lung cancer.